Allecra Theraps Drug Patent Portfolio

Allecra Theraps owns 1 orange book drug protected by 2 US patents Given below is the list of Allecra Theraps's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11124526 Crystalline beta-lactamase inhibitor 07 Nov, 2034
Active
US7687488 2-substituted methyl penam derivatives 03 Dec, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Allecra Theraps.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA) 03 Jul, 2024 US7687488
Email Notification 03 Jul, 2024 US7687488
Initial letter Re: PTE Application to regulating agency 25 Apr, 2024 US7687488
Initial letter Re: PTE Application to regulating agency 25 Apr, 2024 US11124526
Requirement for information sent under 37 CFR 1.750 25 Apr, 2024 US7687488
Payment of Maintenance Fee, 12th Year, Large Entity 22 Sep, 2021 US7687488
Patent Issue Date Used in PTA Calculation 21 Sep, 2021 US11124526
Recordation of Patent Grant Mailed 21 Sep, 2021 US11124526
Email Notification 02 Sep, 2021 US11124526
Issue Notification Mailed 01 Sep, 2021 US11124526
Application Is Considered Ready for Issue 18 Aug, 2021 US11124526
Dispatch to FDC 18 Aug, 2021 US11124526
Issue Fee Payment Received 16 Aug, 2021 US11124526
Issue Fee Payment Verified 16 Aug, 2021 US11124526
Email Notification 17 May, 2021 US11124526


Allecra Theraps's Family Patents


Family Patents



Allecra Theraps Drug List

Given below is the complete list of Allecra Theraps's drugs and the patents protecting them.


1. Exblifep

Exblifep is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11124526 Crystalline beta-lactamase inhibitor 07 Nov, 2034
(10 years from now)
Active
US7687488 2-substituted methyl penam derivatives 03 Dec, 2027
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exblifep's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List